At a Capitol Hill event organized by AAAS, experts discussed the legal challenges facing the fast-growing industry.

As new drugs and medical devices make their way through the FDA’s approval process at an accelerated rate, research on their safety and efficacy is not always as rigorous as it should be, experts cautioned at a AAAS event.

Drugs that help premature babies strengthen their lungs can also impair brain development even at low doses, reports a new study in the journal Science Translational Medicine. This study brings new knowledge to the table that could help doctors and parents make more informed decisions on how to treat preemies.